GORE TAG Thoracic Branch Endoprosthesis TAC123720ARecalls & reported problems
W. L. Gore & Associates, Inc. · TAG TBE AORTIC COMPONENT TAG TBE AC 12MMX37MMX20CM · Class 3 · Implant
All models of GORE TAG Thoracic Branch Endoprosthesis (30)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00733132654222), received between Apr 9, 2026 and Apr 9, 2026 — classified as 1 injury.
The most frequently reported specific device problem is “Device Endoleak” (1 report).
1 other recall cover devices cleared under the same FDA submission (P210032); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Device Endoleak1
- Use of Device Problem1
Patient problems
- Clinical Endoleak1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryApr 9, 2026Use of Device Problem; Device Endoleak
ON (B)(6) 2025, THE PATIENT UNDERWENT AN ENDOVASCULAR PROCEDURE UTILIZING A PHYSICIAN-MODIFIED GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS (TBE) IN ZONE 0 OF THE THORACIC AORTA. ON (B)(6) 2026, THE FIELD SALES ASSOCIATE (FSA) WAS MADE AWARE THAT THE PHYSICIAN WAS PLANNING TO REINTERVENE ON THE PATIENT DUE TO A POTENTIAL TYPE 1A AND TYPE 2 ENDOLEAKS. REPORTEDLY, THE TYPE 1A ENDOLEAK WAS CAUSED BY THE PHYSICIAN UNDERSIZING THE TBE IN THE PATIENT'S ANATOMY. IT IS UNKNOWN IF THERE WAS ANY ANEURYSM ENLARGEMENT ASSOCIATED WITH THE POTENTIAL ENDOLEAKS. ON (B)(6) 2026, THE PATIENT UNDERWENT A REINTERVENTION PROCEDURE TO ADD PROXIMAL EXTENSION TO THE PREVIOUSLY IMPLANTED TBE IN THE ASCENDING AORTA UTILIZING GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM (CTAG). REPORTEDLY DURING THE PROCEDURE, THE PRIMARY DEPLOYMENT LINE BROKE, BUT THE BACKUP HATCH WAS USED TO SUCCESSFULLY COMPLETE DEPLOYMENT. WHEN THE DEPLOYMENT LINE BROKE, THE DEVICE PARTIALLY "FLOWERED", AND THE PATIENT'S BLOOD PRESSURE DROPPED TO ZERO DUE TO AN INCOMPETENT AORTIC VALVE ACCORDING TO THE PHYSICIAN. ONCE THE DEVICE WAS DEPLOYED SUCCESSFULLY USING THE BACKUP HATCH, THE PATIENT'S BLOOD PRESSURE RECOVERE
Patient problems: Clinical Endoleak
MAUDE report 24829445 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P210032. One submission often covers many models, so check the product and lot details in each record.
- Z-2672-2026 · May 19, 2026 · Open, ClassifiedGORE TAG Thoracic Branch Endoprosthesis Side Branch Component Catalog Numbers (by Region) United States (includes Puerto Rico) and Canada: TSB080806A, TSB081006A, TSB081206A, TSB08
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page